Effect of natalizumab on disease activity in relapsing-remitting multiple sclerosis patients

被引：0
|
作者：
Agiela, Mabroka I. M. [1 ]
机构：
[1] Benghazi Med Ctr, Benghazi, Libya
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
12
引用
收藏
页码：NP5 / NP5
页数：1
相关论文
共 50 条
  • [1] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [2] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    [J]. NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [3] Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis
    Melin, A.
    Outteryck, O.
    Collongues, N.
    Zephir, H.
    Fleury, M. C.
    Blanc, F.
    Lacour, A.
    Ongagna, J. C.
    Berteloot, A. S.
    Vermersch, P.
    de Seze, J.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (06) : 1215 - 1221
  • [4] Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis
    A. Melin
    O. Outteryck
    N. Collongues
    H. Zéphir
    M. C. Fleury
    F. Blanc
    A. Lacour
    J. C. Ongagna
    A. S. Berteloot
    P. Vermersch
    J. de Sèze
    [J]. Journal of Neurology, 2012, 259 : 1215 - 1221
  • [5] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 : S303 - S303
  • [6] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
  • [7] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
    Rodriguez de Castro, Belen
    Martinez-Mugica Barbosa, Cristina
    Ayastuy Ruiz, Aitor
    Fernandez Gonzalez, Beatriz
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
  • [8] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
  • [9] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
    Arnal-Garcia, Carmen
    Rosa Garcia-Montero, Ma
    Malaga, Ignacio
    Millan-Pascual, Jorge
    Oliva-Nacarino, Pedro
    Ramio-Torrenta, Lluis
    Oreja-Guevara, Celia
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
  • [10] Durable effect of alemtuzumab on disease activity in patients with relapsing-remitting multiple sclerosis
    Wiendl, H.
    Arnold, D. L.
    Hupperts, R. M.
    Giovannoni, G.
    Margolin, D. H.
    Kasten, L.
    Havrdova, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 256 - 256
12345